Mammography radiomics features at diagnosis and progression-free survival among patients with breast cancer

被引:0
|
作者
Chuanxu Luo
Shuang Zhao
Cheng Peng
Chengshi Wang
Kejia Hu
Xiaorong Zhong
Ting Luo
Juan Huang
Donghao Lu
机构
[1] Sichuan University,Laboratory of Molecular Diagnosis of Cancer, Clinical Research Center for Breast, West China Hospital
[2] West China Hospital of Sichuan University,Department of Radiology
[3] Brigham and Women’s Hospital,Channing Division of Network Medicine
[4] University of Electronic Science and Technology of China,Department of breast surgery, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine
[5] Institute of Environmental Medicine,Unit of Integrative Epidemiology
[6] Karolinska Institute,Department of Head, Neck and Mammary Gland Oncology
[7] Cancer Center,West China Biomedical Big Data Center
[8] West China Hospital,undefined
[9] Sichuan University,undefined
[10] West China Hospital,undefined
[11] Sichuan University,undefined
来源
British Journal of Cancer | 2022年 / 127卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1886 / 1892
页数:6
相关论文
共 50 条
  • [31] Potential prognostic factors in progression-free survival for patients with cervical cancer
    Hui-Hui Chen
    Wei-Yu Meng
    Run-Ze Li
    Qing-Yi Wang
    Yu-Wei Wang
    Hu-Dan Pan
    Pei-Yu Yan
    Qi-Biao Wu
    Liang Liu
    Xiao-Jun Yao
    Min Kang
    Elaine Lai-Han Leung
    BMC Cancer, 21
  • [32] Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients
    Hogdall, Estrid
    Fung, Eric T.
    Christensen, Ib Jarle
    Yip, Christine
    Nedergaard, Lotte
    Engelholm, Svend Aage
    Risum, Signe
    Petri, Anette Lykke
    Lundvall, Lene
    Lomas, Lee
    Hogdall, Claus
    PROTEOMICS CLINICAL APPLICATIONS, 2010, 4 (12) : 940 - 952
  • [33] The value of progression-free survival to patients with advanced-stage cancer
    Lesley J. Fallowfield
    Anne Fleissig
    Nature Reviews Clinical Oncology, 2012, 9 : 41 - 47
  • [34] The value of progression-free survival to patients with advanced-stage cancer
    Fallowfield, Lesley J.
    Fleissig, Anne
    NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (01) : 41 - 47
  • [35] A Proposal for Progression-Free Survival Assessment in Patients with Early Progressive Cancer
    Tanase, Takanori
    Hamada, Chikuma
    Yoshino, Takayuki
    Ohtsu, Atsushi
    ANTICANCER RESEARCH, 2017, 37 (10) : 5851 - 5855
  • [36] Development of a nomogram to predict the progression-free survival in lung cancer patients
    Tafenzi, H. A.
    Choulli, F.
    Baladi, A.
    El Fadli, M.
    Essadi, I.
    Belbaraka, R.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S155 - S155
  • [37] Potential prognostic factors in progression-free survival for patients with cervical cancer
    Chen, Hui-Hui
    Meng, Wei-Yu
    Li, Run-Ze
    Wang, Qing-Yi
    Wang, Yu-Wei
    Pan, Hu-Dan
    Yan, Pei-Yu
    Wu, Qi-Biao
    Liu, Liang
    Yao, Xiao-Jun
    Kang, Min
    Leung, Elaine Lai-Han
    BMC CANCER, 2021, 21 (01)
  • [38] Overall and progression-free survival in young breast cancer patients with low muscle mass and density.
    Greiner, Rebecca Sheaff
    Flores, Matthew
    Boselli, Danielle
    Stone, Taylor
    Hadzikadic-Gusic, Lejla
    Hecksher, Anna
    Bailey-Dorton, Chasse Margot
    Wang, Eric
    Walsh, Declan
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [39] Shape features predicting intrahepatic progression-free and overall survival for SBRT treated HCC patients using radiomics and deep learning based survival models
    Wei, Lise
    Jiang, Jue
    Veeraraghavan, Harini
    El Naqa, Issam
    CLINICAL CANCER RESEARCH, 2021, 27 (05)
  • [40] Thymidylate synthase expression as a predictive factor for response and progression-free survival in metastatic breast cancer patients
    Seki, Hirohito
    Jinno, Hiromitsu
    Hayashida, Tetsu
    Takahashi, Maiko
    Kaneda, Munehisa
    Suzuki, Keiichi
    Hara, Hidenori
    Osaku, Masayoshi
    Yamada, Yoshinori
    Asamuna, Humiki
    Kitagawa, Yuko
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)